Bay­er starts work on $43M+ ex­pan­sion of OTC man­u­fac­tur­ing site in Penn­syl­va­nia

Ger­man phar­ma gi­ant Bay­er will be look­ing to make a sig­nif­i­cant in­vest­ment in­to one of its US plants that pro­duces over-the-counter drugs.

Bay­er an­nounced that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER